drugset / Trial / NCT00843024

Migraine Study in Adolescent Patients

NCT00843024

Phase 3 Completed 589 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was designed to determine how well the combination medication, sumatriptan and naproxen sodium, treats migraine headache in adolescents 12-17 years old

Timeline

Start
2008-12
Primary completion
2010-05
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule 60 mg
Subject Naproxen Small molecule 180 mg
Subject Naproxen Small molecule 500 mg
Subject Sumatriptan Unknown 10 mg
Subject Sumatriptan Unknown 30 mg
Subject Sumatriptan Unknown 85 mg

Indications